NanoFL is a miniaturized platform diagnostic for highly specific diagnostic analysis of fluorescent samples at the point-of-use. The system was designed to be used in environments where large, delicate or expensive diagnostic equipment would not be suitable, but a laboratory level of sensitivity is still required.

The NanoFL platform can be used as a stand-alone, application-specific device or as an integrated component of a larger system.

The underlying heart of the device is its simple flexibility. Pria has tested the platform with a variety of fluid-based samples such as cells and proteins with labels ranging from FITC to quantum dots.

Unlike current solid-state rapid tests, quantitatively analyzing fluid samples allows a level of diagnostic sensitivity necessary for complex infectious disease testing. Using the NanoFL platform, Pria is developing several diagnostic applications, including CD4+ monitors for HIV patients and handheld devices for the detection of as-of-yet unidentified diseases.